Seebri Neohaler
NDC Package 63402-815-06

The code 63402-815-06 identifies a specific commercial package of 1 blister pack in 1 carton / 6 capsule in 1 blister pack (63402-815-01) / 1 capsule in 1 capsule of Seebri Neohaler, labeled by Sunovion Pharmacueticals Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This is formulated for use and contains as the active substance.

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Sunovion Pharmacueticals Inc. on October 29, 2017. The current certification is valid through October 31, 2021.

Glycopyrrolate is a long term medication used to treat ongoing lung disease such as chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It must be used regularly to reduce and prevent symptoms such as shortness of breath and wheezing. This may lead to a decrease in time lost from work due to COPD. This medication belongs to a class of drugs known as anticholinergics. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Glycopyrrolate does not work right away and should not be used to relieve sudden breathing problems. If wheezing or sudden shortness of breath occurs, use your quick-relief inhaler as prescribed.

For medical billing and reimbursement, this package follows the 11-digit CMS format: 63402081506. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.